Alnylam Pharmaceuticals
ALNY
#1121
Rank
ยฃ15.84 B
Marketcap
ยฃ118.33
Share price
-2.00%
Change (1 day)
-65.69%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company